REPORTED DEVELOPMENT

The same consumer study reports activewear fit priorities rising from 29% in 2025 to 54% in 2026, while inclusive-sizing priorities fall from 55% in 2024 to 37% in 2026. The comparisons have different baseline years. A GLP-1-related interpretation is not causal proof.

WHY IT MATTERS TO THE MARKET

Fit and sizing demand inform product data, assortment and returns analysis, but differing baselines and explanations must remain explicit.

MARKET EVIDENCE

SOURCE-LINKED INDICATORS

The consumer evidence is a surveyed preference, not a measured shift in garments purchased.

54%Activewear shoppers naming consistent fit/sizing importantCONSUMER SURVEY2026 / US / AlixPartners Consumer Sentiment IndexUS survey of stated shopping preferences; year-on-year fit/sizing comparisons do not establish a causal medication effect or measured returns.ALIXPARTNERS / VIEW SOURCE
29%Previous comparison on the same fit/sizing questionCONSUMER SURVEY2025 / US / activewear shoppers / prior survey waveUS survey of stated shopping preferences; year-on-year fit/sizing comparisons do not establish a causal medication effect or measured returns.ALIXPARTNERS / VIEW SOURCE
WHAT THE DATA SUGGESTS

More prominent sizing concerns may justify stronger fit data, size-chart reliability and return-cause analysis before revising assortment or sampling policy.

INTERPRETATION BOUNDARY

The responses measure stated importance, not changes in body size or returns. Cross-year shifts cannot establish a causal GLP-1 effect.

ORIGINAL REFERENCES